The Alternative Splicing of ApoER 2 in Alzheimer ’ s Disease
暂无分享,去创建一个
Kate E. McCaffrey | Dawn N. Abt | R. Glassman | S. Debburman | Francine M. Jodelka | Mallory A. Havens | Michael T. Orr | A. Hinrich | Mallory A Havens | C. Wee | Ashley A. Reich | A. Case | Daniella Brutman
[1] M. Weiner,et al. The dynamics of cortical and hippocampal atrophy in Alzheimer disease. , 2011, Archives of neurology.
[2] Ruth Williams,et al. Biomarkers: Warning signs , 2011, Nature.
[3] Alzheimer’s Association,et al. 2011 Alzheimer’s disease facts and figures , 2011, Alzheimer's & Dementia.
[4] Karl Herrup,et al. Reimagining Alzheimer's Disease—An Age-Based Hypothesis , 2010, The Journal of Neuroscience.
[5] C. Lippa,et al. Review: Disruption of the Postsynaptic Density in Alzheimer’s Disease and Other Neurodegenerative Dementias , 2010, American journal of Alzheimer's disease and other dementias.
[6] Xiongwei Zhu,et al. Mitochondrial biology in Alzheimer’s disease pathogenesis , 2010, Journal of neurochemistry.
[7] M. Pleckaityte,et al. [Alzheimer's disease: a molecular mechanism, new hypotheses, and therapeutic strategies]. , 2010, Medicina.
[8] V. Hachinski,et al. Changing perspectives regarding late-life dementia , 2009, Nature Reviews Neurology.
[9] F. Schmitt,et al. Expression of SORL1 and a novel SORL1 splice variant in normal and Alzheimers disease brain , 2009, Molecular Neurodegeneration.
[10] C. White,et al. Reelin signaling antagonizes β-amyloid at the synapse , 2009, Proceedings of the National Academy of Sciences.
[11] Frederico A. C. Azevedo,et al. Equal numbers of neuronal and nonneuronal cells make the human brain an isometrically scaled‐up primate brain , 2009, The Journal of comparative neurology.
[12] A. Baba,et al. Splicing variations in the ligand-binding domain of ApoER2 results in functional differences in the binding properties to Reelin , 2009, Neuroscience Research.
[13] R. Mayeux,et al. Memory performance is related to amyloid and tau pathology in the hippocampus , 2009, Journal of Neurology, Neurosurgery, and Psychiatry.
[14] G. D’Arcangelo,et al. The Reelin Signaling Pathway Promotes Dendritic Spine Development in Hippocampal Neurons , 2008, The Journal of Neuroscience.
[15] J. Takagi,et al. Structure of a receptor-binding fragment of reelin and mutational analysis reveal a recognition mechanism similar to endocytic receptors , 2007, Proceedings of the National Academy of Sciences.
[16] D. Selkoe,et al. Aβ Oligomers – a decade of discovery , 2007, Journal of neurochemistry.
[17] J. Herz,et al. Reelin, lipoprotein receptors and synaptic plasticity , 2006, Nature Reviews Neuroscience.
[18] W. Schneider,et al. Reconstitution of the Reelin Signaling Pathway in Fibroblasts Demonstrates that Dab1 Phosphorylation Is Independent of Receptor Localization in Lipid Rafts , 2006, Molecular and Cellular Biology.
[19] M. Frotscher,et al. Modulation of Synaptic Plasticity and Memory by Reelin Involves Differential Splicing of the Lipoprotein Receptor Apoer2 , 2005, Neuron.
[20] B. Hyman,et al. The apoE isoform binding properties of the VLDL receptor reveal marked differences from LRP and the LDL receptor Published, JLR Papers in Press, May 1, 2005. DOI 10.1194/jlr.M500114-JLR200 , 2005, Journal of Lipid Research.
[21] E. Weeber,et al. Reelin, Very-Low-Density Lipoprotein Receptor, and Apolipoprotein E Receptor 2 Control Somatic NMDA Receptor Composition during Hippocampal Maturation In Vitro , 2005, The Journal of Neuroscience.
[22] G. Gamkrelidze,et al. ApoE isoform-specific effects on LTP: blockade by oligomeric amyloid-β1–42 , 2005, Neurobiology of Disease.
[23] J. Richardson,et al. Cognitive correlates of Aβ deposition in male and female mice bearing amyloid precursor protein and presenilin-1 mutant transgenes , 2004, Brain Research.
[24] David A. Bennett,et al. Apolipoprotein gene and its interaction with the environmentally driven risk factors: molecular, genetic and epidemiological studies of Alzheimer’s disease , 2004, Neurobiology of Aging.
[25] B. Zlokovic. Clearing amyloid through the blood–brain barrier , 2004, Journal of neurochemistry.
[26] D. Bennett,et al. Alzheimer disease in the US population: prevalence estimates using the 2000 census. , 2003, Archives of neurology.
[27] L. Murri,et al. Causative and susceptibility genes for Alzheimer’s disease: a review , 2003, Brain Research Bulletin.
[28] A. Goffinet,et al. Reelin and brain development , 2003, Nature Reviews Neuroscience.
[29] J. Woo,et al. Low-density lipoprotein receptor-related protein 8 (apolipoprotein E receptor 2) gene polymorphisms in Alzheimer's disease , 2002, Neuroscience Letters.
[30] J. Sweatt,et al. Reelin and ApoE Receptors Cooperate to Enhance Hippocampal Synaptic Plasticity and Learning* , 2002, The Journal of Biological Chemistry.
[31] S. Liebhaber,et al. Targeting a KH-domain protein with RNA decoys. , 2002, RNA.
[32] B. Oken. Practice parameter: Management of dementia (an evidence-based review) , 2001, Neurology.
[33] Yasuhiro Nakamura,et al. Significance of the variant and full-length forms of the very low density lipoprotein receptor in brain , 2001, Brain Research.
[34] A. Krainer,et al. Exon identity established through differential antagonism between exonic splicing silencer-bound hnRNP A1 and enhancer-bound SR proteins. , 2001, Molecular cell.
[35] M. Sheng,et al. Dentritic spines : structure, dynamics and regulation , 2001, Nature Reviews Neuroscience.
[36] W. Schneider,et al. Alternative Splicing in the Ligand Binding Domain of Mouse ApoE Receptor-2 Produces Receptor Variants Binding Reelin but Not α2-Macroglobulin* , 2001, The Journal of Biological Chemistry.
[37] E. Wagner,et al. Polypyrimidine Tract Binding Protein Antagonizes Exon Definition , 2001, Molecular and Cellular Biology.
[38] B. Graveley. Sorting out the complexity of SR protein functions. , 2000, RNA.
[39] W. Schneider,et al. The Reelin Receptor ApoER2 Recruits JNK-interacting Proteins-1 and -2* , 2000, The Journal of Biological Chemistry.
[40] Joachim Herz,et al. Direct Binding of Reelin to VLDL Receptor and ApoE Receptor 2 Induces Tyrosine Phosphorylation of Disabled-1 and Modulates Tau Phosphorylation , 1999, Neuron.
[41] N. Shen,et al. Patterns of single-nucleotide polymorphisms in candidate genes for blood-pressure homeostasis , 1999, Nature Genetics.
[42] Jonathan A. Cooper,et al. Reelin-induced tryosine phosphorylation of Disabled 1 during neuronal positioning , 1999 .
[43] J. Nevins,et al. Inhibition of cell proliferation by an RNA ligand that selectively blocks E2F function , 1996, Nature Medicine.
[44] L. Mucke,et al. Alzheimer-type neuropathology in transgenic mice overexpressing V717F β-amyloid precursor protein , 1995, Nature.
[45] B. Hyman,et al. Apolipoprotein E in sporadic Alzheimer's disease: Allelic variation and receptor interactions , 1993, Neuron.
[46] C. Cotman,et al. Apoptosis is induced by beta-amyloid in cultured central nervous system neurons. , 1993, Proceedings of the National Academy of Sciences of the United States of America.
[47] J. Haines,et al. Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families. , 1993, Science.
[48] Paul D. Coleman,et al. Neuron numbers and dendritic extent in normal aging and Alzheimer's disease , 1987, Neurobiology of Aging.
[49] R. Glockshuber,et al. Amyloid-beta aggregation. , 2007, Neuro-degenerative diseases.
[50] Molecular Neurodegeneration BioMed Central Review The generation and function of soluble apoE receptors in the CNS , 2006 .
[51] S. Wiebe,et al. Report of the Quality Standards Subcommittee of the American Academy of Neurology, in Association with the American Epilepsy Society and the American Association of Neurological Surgeons , 2003 .
[52] J. Hardy,et al. Accelerated Alzheimer-type phenotype in transgenic mice carrying both mutant amyloid precursor protein and presenilin 1 transgenes , 1998, Nature Medicine.
[53] Weiming Xia,et al. Mutant presenilins of Alzheimer's disease increase production of 42-residue amyloid β-protein in both transfected cells and transgenic mice , 1997, Nature Medicine.
[54] D. Selkoe. Alzheimer's disease: genotypes, phenotypes, and treatments. , 1997, Science.
[55] J. Ma,et al. Amyloid-associated proteins alpha 1-antichymotrypsin and apolipoprotein E promote assembly of Alzheimer beta-protein into filaments. , 1994, Nature.
[56] A. Alzheimer. Uber eine eigenartige Erkrankung der Hirnrinde , 1907 .